On March 11, 2026, National Vision CEO Alexander Wilkes executed a significant sale of 35,000 shares of the company’s common stock, valued at approximately $26.54 per share, as disclosed in a SEC Form 4 filing. This transaction, the first open-market sale by Wilkes in recent reporting periods, reduced his direct holdings by 68.05%, leaving him with 16,431 shares. Notably, the sale was conducted under a pre-established Rule 10b5-1 trading plan, indicating it was planned rather than opportunistic.
This sale comes in the context of National Vision’s strong stock performance, with shares up 118.4% over the past year and reaching a 52-week high of $30.02 in January. The company recently reported a 15% year-over-year revenue increase in its fiscal fourth quarter, highlighting its operational efficiency and strong demand for affordable vision care. However, the current price-to-earnings ratio of 72 suggests that the stock may now be overvalued.
Investors should view Wilkes’ transaction as a routine part of a planned trading strategy rather than a signal of underlying issues. With the stock’s recent gains, this may be a prudent time for investors to reassess their positions in National Vision.
Source: fool.com